Assay | Control | Emodin | 3-MC |
---|---|---|---|
Peroxide production (fluorescence unit) | 397 ± 16 | 2,174 ± 2844-a | 354 ± 2 |
Glutathione content (nmol/mg of protein) | 19.6 ± 0.2 | 39.3 ± 2.84-a | 39.5 ± 0.74-a |
Benzo[a]pyrene hydroxylation (pmol of OHBP/min/mg of protein) | 0.1 ± 0.0 | 0.4 ± 0.14-a | 3.9 ± 0.64-a |
7-EthoxyresorufinO-deethylation (pmol of RF/min/mg of protein) | 0.2 ± 0.1 | 2.6 ± 0.24-a | 5.0 ± 0.14-a |
7-EthoxycoumarinO-deethylation (pmol of HC/min/mg of protein) | 0.1 ± 0.0 | 1.6 ± 0.44-a | 6.8 ± 1.44-a |
CL5 cells were treated with 100 μM emodin or 10 μM 3-MC for 24 h. Control cells were treated with DMSO only. Cell homogenate and S9 fractions were prepared for total glutathione content and drug-metabolizing enzyme activity determinations, as described underMaterials and Methods, respectively. In peroxide study, the cells were treated with 5 μM DCFH-DA for 2 h before analysis of fluorescence of DCFH using a flow cytometer. Each value represents mean ± S.E. for three experiments.
↵4-a Value significantly different from the respective control value, p < 0.05.